Smart Carbon Fiber-Reinforced Polymer Composites for Damage Sensing and On-Line Structural Health Monitoring Applications.

High electrical conductivity, along with high piezoresistive sensitivity and stretchability, are crucial for designing and developing nanocomposite strain sensors for damage sensing and on-line structural health monitoring of smart carbon fiber-reinforced polymer (CFRP) composites. In this study, the influence of the geometric features and loadings of carbon-based nanomaterials, including reduced graphene oxide (rGO) or carbon nanofibers (CNFs), on the tunable strain-sensing capabilities of epoxy-based nanocomposites was investigated. This work revealed distinct strain-sensing behavior and sensitivities (gauge factor, GF) depending on both factors.

A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years.

Dupilumab has been shown to be a safe and effective drug for the treatment of atopic dermatitis (AD) in children from 6 months to 11 years in randomized clinical trials. Aim: The aim of this real-life study was to determine the effectiveness in disease control and safety of dupilumab at W52 in moderate-to-severe AD children aged 6-11 years. All data were collected from 36 Italian dermatological or paediatric referral centres.

Investigation of Carbon Fibres Reclamation by Pyrolysis Process for Their Reuse Potential.

During Carbon Fibre Reinforced Polymers (CFRPs) manufacturing, large quantities of scrap are being produced and usually disposed to landfill or incinerated, resulting in a high environmental impact. Furthermore, CFRP parts that have been damaged or reached their end-of-life, follow the same disposal route and because of this, not only the environment is affected, but also high added-value materials, such as carbon fibres (CFs) are lost without further valorisation. Several recycling technologies have been suggested, such as pyrolysis, to retrieve the CF reinforcement from the CFRPs.

Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study.

Background: The management of paediatric atopic dermatitis (AD) is challenging, mostly relying on emollients and topical corticosteroids. Dupilumab, a fully human monoclonal antibody, has been recently approved for the treatment of children aged 6-11 years with moderate-to-severe AD not adequately controlled with topical therapies or when those therapies are not advisable.

Objectives: The aim of this study was to evaluate in real life the effectiveness and safety of dupilumab in the treatment of children aged from 6 to 11 years.

The Impact of Carbon Nanofibres on the Interfacial Properties of CFRPs Produced with Sized Carbon Fibres.

In this work, different amounts of CNFs were added into a complex formulation to coat the CFs surfaces via sizing in order to enhance the bonding between the fibre and the resin in the CF-reinforced polymer composites. The sized CFs bundles were characterised by SEM and Raman. The nanomechanical properties of the composite materials produced were assessed by the nanoindentation test.